Inventor · disambiguated record
Ping Chen
Also filed as: CHEN PING · CHEN PING-CHI BENJAMIN
49 granted patents·13 pending applications·1,010 citations·filing 1994–2023
98Inventor score
Files withBRISTOL MYERS SQUIBB CO31PFIZER11UAB RESEARCH FOUNDATION3VIVA STAR BIOSCIENCES SUZHOU CO LTD3FINK BRIAN E2
Top patents by PatentIndex Score
62 records- 0198US6596746B1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 22, 2003·257 cites·49 claims
- 0297US7153856B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·38 cites·8 claims
- 0396US11220494B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2020·Granted Jan 11, 2022·13 cites·21 claims
- 0496US9382219B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 5, 2016·17 cites·11 claims
- 0595US10766884B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2019·Granted Sep 8, 2020·19 cites·20 claims
- 0695US7189854B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Mar 13, 2007·26 cites·8 claims
- 0794US7125875B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 24, 2006·74 cites·27 claims
- 0893US5990109AHeterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Nov 23, 1999·163 cites·42 claims
- 0992US7605160B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 20, 2009·28 cites·11 claims
- 1092US6653304B2Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 25, 2003·62 cites·8 claims
- 1192US5481011AProcess for preparing N-protected amino acid α-halomethyl ketones and alcohols from N-protected amino acid estersBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jan 2, 1996·45 cites·16 claims
- 1291US6916809B2Heterocyclic acridone inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 12, 2005·61 cites·9 claims
- 1390US7091223B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 15, 2006·21 cites·12 claims
- 1490US6979694B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 27, 2005·23 cites·11 claims
- 1589US8716323B2Cyclic protein tyrosine kinase inhibitorsDAS JAGABANDHU·Filed 2005·Granted May 6, 2014·9 cites·20 claims
- 1689US7531539B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 12, 2009·18 cites·10 claims
- 1789US7297695B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 20, 2007·9 cites·4 claims
- 1888US7151176B2Pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 19, 2006·12 cites·5 claims
- 1986US10662204B2Substituted quinazoline and pyridopyrimidine derivatives useful as anticancer agentsPFIZER·Filed 2019·Granted May 26, 2020·4 cites·21 claims
- 2086US6342385B1Mutacin I biosynthesis genes and proteinsUAB RESEARCH FOUNDATION·Filed 2000·Granted Jan 29, 2002·12 cites·4 claims
- 2185US8530487B1Compounds useful for treating disorders related to TRPA1WU XINYUAN·Filed 2010·Granted Sep 10, 2013·4 cites·11 claims
- 2284US9260439B2Dihydropyrrolopyrimidine derivativesPFIZER·Filed 2015·Granted Feb 16, 2016·3 cites·18 claims
- 2383US8993567B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 31, 2015·3 cites·12 claims
- 2480US10590115B2Tetrahydroquinazoline derivatives useful as anticancer agentsPFIZER·Filed 2019·Granted Mar 17, 2020·2 cites·14 claims
- 2580US8034940B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 11, 2011·4 cites·11 claims
- 2678US7514435B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 7, 2009·3 cites·6 claims
- 2778US7141571B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·8 cites·4 claims
- 2877US7064203B2Di-substituted pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jun 20, 2006·9 cites·6 claims
- 2977US6699970B2Mutacin I biosynthesis genes and proteinsUAB RESEARCH FOUNDATION·Filed 2002·Granted Mar 2, 2004·3 cites·2 claims
- 3076US7846931B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 7, 2010·1 cites·1 claims
- 3175US12378232B2Cyclin dependent kinase inhibitorsPFIZER·Filed 2021·Granted Aug 5, 2025·0 cites·2 claims
- 3275US7982033B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 19, 2011·2 cites·4 claims
- 3375US2022324872A1CDK2/4/6 InhibitorsPFIZER·Filed 2022·Application pending·0 cites
- 3474US6235740B1Imidazoquinoxaline protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 1998·Granted May 22, 2001·45 cites·41 claims
- 3572US2019210986A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3669US8389527B2Substituted imidazopyridazines useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Mar 5, 2013·1 cites·12 claims
- 3767US11396512B2CDK2/4/6 inhibitorsPFIZER·Filed 2020·Granted Jul 26, 2022·0 cites·12 claims
- 3867US10800783B2CDK2/4/6 inhibitorsPFIZER·Filed 2019·Granted Oct 13, 2020·0 cites·16 claims
- 3967US2018016247A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4064US9012465B1Compounds useful for treating disorders related to TRPA1WU XINYUAN·Filed 2013·Granted Apr 21, 2015·0 cites·2 claims
- 4164US7655236B2Lanthionine antibiotic compositions and methodsUAB RESEARCH FOUNDATION·Filed 2004·Granted Feb 2, 2010·0 cites·20 claims
- 4264US2016264537A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 4363US9505756B2Compounds useful for treating disorders related to TRPA1HYDRA BIOSCIENCES INC·Filed 2015·Granted Nov 29, 2016·0 cites·20 claims
- 4461US2025325706A1Linker peptide, fviii protein or variant thereof containing linker peptide, and use thereofSHENZHEN SYNO MINICIRCLE BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 4561US2018051020A1Compounds useful for treating disorders related to trpa1HYDRA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 4658US2024293558A1Kras inhibitor conjugatesERASCA INC·Filed 2022·Application pending·0 cites
- 4754US6670167B1Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereofAGOURON PHARMA·Filed 1999·Granted Dec 30, 2003·11 cites·17 claims
- 4854US2011039838A1Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 4952US12338255B2Bicyclic substituted sulfonylurea compounds as inhibitors of interleukin-1 activityVIVA STAR BIOSCIENCES SUZHOU CO LTD·Filed 2023·Granted Jun 24, 2025·0 cites·19 claims
- 5052US11203594B2Anti-proliferative agents for treating PAHPFIZER·Filed 2020·Granted Dec 21, 2021·0 cites·30 claims
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ping Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →